These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19241485)

  • 21. Laparoscopic staging and radiofrequency of hepatocellular carcinoma in liver ci rrhosis. A "bridge" treatment to liver transplantation.
    Casaccia M; Andorno E; Nardi I; Santori G; Troilo B; Barabino G; Di Domenico S; Panaro F; Valente U
    Hepatogastroenterology; 2009; 56(91-92):793-7. PubMed ID: 19621704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting survival in early hepatocellular carcinoma.
    Ryder S
    Gut; 2005 Mar; 54(3):328-9. PubMed ID: 15710977
    [No Abstract]   [Full Text] [Related]  

  • 23. Should the selection of children with hepatocellular carcinoma be based on Milan criteria?
    Otte JB
    Pediatr Transplant; 2008 Feb; 12(1):1-3. PubMed ID: 18086239
    [No Abstract]   [Full Text] [Related]  

  • 24. Is the search for a single comprehensive staging system for hepatocellular carcinoma an elusive one?
    McClune AC; Tong MJ
    J Clin Gastroenterol; 2009 Sep; 43(8):697-8. PubMed ID: 19636257
    [No Abstract]   [Full Text] [Related]  

  • 25. Selection of HCC patients for liver transplantation: the Milan criteria, Hangzhou criteria and beyond.
    Fan ST
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):233-4. PubMed ID: 18522876
    [No Abstract]   [Full Text] [Related]  

  • 26. Selection criteria for patients with hepatocellular carcinoma in liver transplantation.
    Kaido T; Takada Y; Uemoto S
    Transplantation; 2009 Aug; 88(3):442-3; author reply 443. PubMed ID: 19667951
    [No Abstract]   [Full Text] [Related]  

  • 27. More options and improved outcomes for hepatocellular carcinoma.
    Scoggins CR
    J Surg Oncol; 2008 Aug; 98(2):74. PubMed ID: 18623036
    [No Abstract]   [Full Text] [Related]  

  • 28. Reassessing the boundaries of liver transplantation for hepatocellular carcinoma: Where do we stand with tumor down-staging?
    Yao FY; Fidelman N
    Hepatology; 2016 Mar; 63(3):1014-25. PubMed ID: 26560491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathologic characteristics of hepatocellular carcinoma.
    Nakashima T; Kojiro M
    Semin Liver Dis; 1986 Aug; 6(3):259-66. PubMed ID: 3022387
    [No Abstract]   [Full Text] [Related]  

  • 30. Transarterial chemoembolization for hepatocellular carcinoma with portal vein invasion: a helpful palliative approach.
    Schumacher G; Gebauer B
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1317-9. PubMed ID: 19702898
    [No Abstract]   [Full Text] [Related]  

  • 31. Angiogenesis and hepatocellular carcinoma.
    Semela D; Dufour JF
    J Hepatol; 2004 Nov; 41(5):864-80. PubMed ID: 15519663
    [No Abstract]   [Full Text] [Related]  

  • 32. Blood supply of early hepatocellular carcinoma.
    Bhattacharya S; Davidson B; Dhillon AP
    Semin Liver Dis; 1995 Nov; 15(4):390-401. PubMed ID: 8578322
    [No Abstract]   [Full Text] [Related]  

  • 33. Liberal selection criteria for liver transplantation for hepatocellular carcinoma.
    Muscari F; Foppa B; Kamar N; Peron JM; Selves J; Suc B
    Br J Surg; 2009 Jul; 96(7):785-91. PubMed ID: 19526621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Who should get a liver graft?
    Freeman RB; Jamieson N; Schaubel DE; Porte RJ; Villamil FG
    J Hepatol; 2009 Apr; 50(4):664-73. PubMed ID: 19233503
    [No Abstract]   [Full Text] [Related]  

  • 35. Staging for hepatocellular carcinoma: treatment strategy matters.
    Huo TI; Huang YH
    Hepatology; 2005 Mar; 41(3):678; author reply 678-9. PubMed ID: 15723331
    [No Abstract]   [Full Text] [Related]  

  • 36. Re: Design and endpoints of clinical trials in hepatocellular carcinoma.
    Di Maio M; Daniele B; Gallo C; Perrone F
    J Natl Cancer Inst; 2008 Nov; 100(21):1557; author reply 1557-8. PubMed ID: 18957679
    [No Abstract]   [Full Text] [Related]  

  • 37. Low recurrence rate of hepatocellular carcinoma after liver transplantation: better patient selection or lower immunosuppression?
    Weber M; Kadry Z; Clavien PA
    Transplantation; 2002 Dec; 74(12):1664-5. PubMed ID: 12499876
    [No Abstract]   [Full Text] [Related]  

  • 38. Staging for hepatocellular carcinoma: look for a perfect classification system.
    Huo TI; Lee SD; Wu JC
    J Hepatol; 2004 Jun; 40(6):1041-2; author reply 1042-3. PubMed ID: 15158351
    [No Abstract]   [Full Text] [Related]  

  • 39. Many staging systems for hepatocellular carcinoma: evolution from Child-Pugh, Okuda to SLiDe.
    Dohmen K
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1227-32. PubMed ID: 15482527
    [No Abstract]   [Full Text] [Related]  

  • 40. Critical evaluation of the different staging systems for hepatocellular carcinoma (Br J Surg 2004; 91: 400-408).
    Vauthey JN; Pawlik TM; Lauwers GY; Nagorney DM; Roh MS; Curley SA; Poon RT; Belghiti J; Greene F; Michael Henderson J
    Br J Surg; 2004 Aug; 91(8):1072. PubMed ID: 15286973
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.